Literature DB >> 24460776

Shape of glucose curve can be used as a predictor for screening prediabetes in obese children.

Chunyan Yin1, Hongai Zhang, Yanfeng Xiao, Weihua Liu.   

Abstract

AIM: We attempted to classify obese children with glucose abnormalities into different categories based on the plasma glucose (PG) at 0, 60, 120 and 180 min and extract the metabolic information from the shape of the PG curve.
METHODS: We recruited 1205 obese children and 325 nonobese children. Their body weight, blood pressure, waist and hip circumferences were measured. An oral glucose tolerance test (OGTT) was carried out, and glucose, insulin and glucagon levels were tested.
RESULTS: There were six forms of abnormal glucose tolerance (AGT) curves in obese children in addition to normal glucose tolerance (NGT). 58.3% of obese children had AGT. BMI, waist circumference, waist-to-hip ratio and systolic blood pressure of each obese group were much higher than in nonobese children (p < 0.05). HOMA-IR increased significantly in obese children with high fasting PG and obese children with high fasting and 3-h PG (p < 0.05), and HOMA-β cell increased significantly in obese children with high 1- and 2-h but low 3-h PG (p < 0.05).
CONCLUSION: Abnormal glucose tolerance was highly prevalent when concerning with glucose values at 60 and 180 min. The shape of PG which contains a net of metabolic information can be a predictor for screening prediabetes. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Abnormal glucose tolerance; Glucagon; Glucose; Insulin; Obese children

Mesh:

Substances:

Year:  2014        PMID: 24460776     DOI: 10.1111/apa.12572

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

1.  Two- vs one-hour glucose tolerance testing: Predicting prediabetes in adolescent girls with obesity.

Authors:  Kannan Kasturi; Anthony U Onuzuruike; Shwetha Kunnam; Lauren B Shomaker; Jack A Yanovski; Stephanie T Chung
Journal:  Pediatr Diabetes       Date:  2018-12-27       Impact factor: 4.866

2.  Time to glucose peak during an oral glucose tolerance test identifies prediabetes risk.

Authors:  Stephanie T Chung; Joon Ha; Anthony U Onuzuruike; Kannan Kasturi; Mirella Galvan-De La Cruz; Brianna A Bingham; Rafeal L Baker; Jean N Utumatwishima; Lilian S Mabundo; Madia Ricks; Arthur S Sherman; Anne E Sumner
Journal:  Clin Endocrinol (Oxf)       Date:  2017-08-06       Impact factor: 3.478

Review 3.  Review of methods for detecting glycemic disorders.

Authors:  Michael Bergman; Muhammad Abdul-Ghani; Ralph A DeFronzo; Melania Manco; Giorgio Sesti; Teresa Vanessa Fiorentino; Antonio Ceriello; Mary Rhee; Lawrence S Phillips; Stephanie Chung; Celeste Cravalho; Ram Jagannathan; Louis Monnier; Claude Colette; David Owens; Cristina Bianchi; Stefano Del Prato; Mariana P Monteiro; João Sérgio Neves; Jose Luiz Medina; Maria Paula Macedo; Rogério Tavares Ribeiro; João Filipe Raposo; Brenda Dorcely; Nouran Ibrahim; Martin Buysschaert
Journal:  Diabetes Res Clin Pract       Date:  2020-06-01       Impact factor: 5.602

4.  Delay in glucose peak time during the oral glucose tolerance test as an indicator of insulin resistance and insulin secretion in type 2 diabetes patients.

Authors:  Xinlei Wang; Xiaoqin Zhao; Ranran Zhou; Yunjuan Gu; Xiaohui Zhu; Zhuqi Tang; Xinlu Yuan; Wei Chen; Rongping Zhang; Chen Qian; Shiwei Cui
Journal:  J Diabetes Investig       Date:  2018-04-20       Impact factor: 4.232

5.  Oral Glucose Tolerance Test Glucose Peak Time Is Most Predictive of Prediabetes and Hepatic Steatosis in Obese Girls.

Authors:  Melanie Cree-Green; Danielle Xie; Haseeb Rahat; Yesenia Garcia-Reyes; Bryan C Bergman; Ann Scherzinger; Cecilia Diniz Behn; Christine L Chan; Megan M Kelsey; Laura Pyle; Kristen J Nadeau
Journal:  J Endocr Soc       Date:  2018-05-07

Review 6.  The Oral Glucose Tolerance Test: 100 Years Later.

Authors:  Ram Jagannathan; João Sérgio Neves; Brenda Dorcely; Stephanie T Chung; Kosuke Tamura; Mary Rhee; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-19       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.